Key Highlights

  • RSSL (ASX:RSSL) gives exposure to 1,976 US small-capitalisation companies from the Russell 2000 index.
  • Healthcare is the largest sector at 20.82%, followed by financial services at 18.12%.
  • Management fees and costs are 0.18%, with a fund size of $25.03 million.
  • Companies below $500 million in value make up roughly 55% of the fund.

Global X Russell 2000 ETF (ASX:RSSL) traded at $11.29 during the trading session on 30 October 2026, up 0.35%, with 2,546 units changing hands. RSSL is one of the broadest US stock exposures on the ASX. Instead of owning the largest names, it spreads investors across nearly 2,000 smaller US companies, so no single stock carries much weight. The fund was admitted to the ASX on 12 February 2025.

Fund Overview

RSSL aims to track the Russell 2000 RIC Capped Net Tax index in US dollars. Fund size is $25.03 million, with 2,225,256 units outstanding. ISIN AU0000379604 and fees are 0.18%. The fund is developed by Global X and is not connected to the London Stock Exchange Group.

Stock Exposure and Sector Mix

The fund holds 1,976 companies, and its ten largest positions total only 3.53%. Those positions include Twist Bioscience at 0.42%, Hut 8 at 0.42%, Moog at 0.36%, JFrog at 0.35%, 10x Genomics at 0.35%, SSR Mining at 0.33%, UMB Financial at 0.32%, BrightSpring Health at 0.31%, Glaukos at 0.31% and Viasat at 0.30%.

Sector weights are healthcare 20.82%, financial services 18.12%, technology 14.45%, industrials 13.24% and consumer cyclical 8.58%. Energy is 6.37% and real estate 6.36%. Exposure is 97.64% US, with small positions in Canada, Brazil and Switzerland.

Market Value Spread

By market value, 54.84% of the fund sits in companies below $500 million, 43.49% in companies between $500 million and $1 billion, and only 1.67% in companies above $1 billion. The fund's stocks are therefore small, and its exposure is tilted accordingly.

Session Trading

RSSL's day range was $11.29 to $11.35, with average daily volume of about 11,083 units. The bid-offer range during the session was $11.26 to $11.29.

How the Portfolio Is Built

RSSL's stock exposure is built from the full Russell 2000 universe rather than from a small hand-picked set. Its 1,976 positions are weighted by market value, so the fund holds many small positions alongside a handful of larger ones. The top ten stocks total under 4%, which means the portfolio's behaviour is shaped by the middle and lower end of the index.

Because so many companies are included, the fund behaves like a broad market sample of US smaller businesses. Individual stock blow-ups have limited impact, while sector trends across healthcare, financials and technology have a bigger aggregate effect.

RSSL is designed to mirror the Russell 2000, a broad index of US smaller companies. The index is reconstituted each year, and the fund follows those changes. Its many positions are weighted by market value, so the portfolio has a long tail of small names that together form most of the exposure.

That broad coverage makes RSSL a useful reference for the results of smaller US businesses as a group, rather than for any particular company or sector.

Key Facts

The fund was admitted to the ASX on 12 February 2025 and is benchmarked to the Russell 2000 RIC Capped Net Tax NR USD index. Its ISIN is AU0000379604, and management fees and costs are 0.18% a year. Fund size is $25.03 million, with 2,225,256 units on issue.

What the Exposure Means

RSSL gives investors wide, low-weight exposure to US smaller companies, with healthcare and financial services leading and very few names dominating. It is the most diversified stock exposure in this group, reflecting the Russell 2000's broad universe.